Non-invasive Prenatal Testing (NIPT) Market Research On BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, Verifi, VisibiliT 2014 – 2022
“The Report Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) – Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 – 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”
About Non-invasive Prenatal Testing Market
Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal *** determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testing market studies the current market scenario and future potential for non-invasive prenatal tests globally. The major non-invasive prenatal tests studied in this report are BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and others (IONA, NACE, etc.). These tests have been extensively analyzed on the basis of factors such as the technology used, cost to patients, reimbursement coverage, accuracy and geographical reach (availability across various countries).
Get Sample Copy of this report @ http://www.marketresearchreports.biz/sample/sample/138993
The historical market size and forecast for each of these tests in terms of revenue (USD Million) and volume (Number of tests performed) have been given in the report for the period 2012 to 2022. In addition, the compounded annual growth rate (CAGR) of the overall non-invasive prenatal test market and the above tests has also been provided in the report for the forecast period 2014 to 2022, considering 2012 and 2013 as the base years. The report on non-invasive prenatal testing market also provides comparative analysis of major tests for the years 2013 and 2022.
View Report @ http://www.marketresearchreports.biz/analysis/138993
In this research study, the global market for non-invasive prenatal testing has been geographically segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The non-invasive prenatal testing market size and forecast in terms of revenue (USD Million) and volume (Number of Tests Performed) for each region has been provided for the period 2012 to 2022 along with the CAGR for the forecast period 2014 to 2022. The non-invasive prenatal testing market study also includes qualitative analysis of the competitive scenario in these regions such as major collaboration and partnership, entry of new entrants, new product launch and other macro economic factors. The market overview section of the report on non-invasive prenatal testing market comprises qualitative analysis of the overall non-invasive prenatal testing market considering the factors determining the market dynamics such as drivers, restraints and opportunities along with the Porter’s five force analysis and market attractiveness analysis. The market overview chapter also provides information such as major chromosomal aneuploidies (Down syndrome, Edwards syndrome, Patau syndrome and monosomy X, and their incidence rate, technological approach for NIPT and major patents issued to players operating in the market and other companies and academic research institutions.
The report also includes a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global non-invasive prenatal testing market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the non-invasive prenatal testing market and accentuate market shares. The report concludes with the profiles of major players in the NIPT market such as Sequenom, Inc., Ariosa Diagnostics, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), BGI Diagnostics, LifeCodexx AG, Laboratory Corporation of America Holdings (LabCorp) and Berry Genomics. Each company profile comprises information such as company overview, financial overview, product portfolio, business strategies and recent developments.
The global non-invasive prenatal testing market is segmented as follows:
Global Non-Invasive Prenatal Testing Market, by Test
Global Non-Invasive Prenatal Testing Market, by Geography
Rest of the World (RoW)
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
220.127.116.11 Secondary Research
18.104.22.168 Primary Research
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)
2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)
2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)
2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)
Chapter 3 Global Non-Invasive Prenatal Testing Market Overview
3.2 Major Chromosomal Aneuploidies and their Incidence Rate
3.2.1 Down Syndrome
3.2.2 Edwards Syndrome
3.2.3 Patau Syndrome
3.2.4 Turner Syndrome
3.2.5 Klinefelter Syndrome
3.2.6 Jacobs Syndrome
3.2.7 Triple X Syndrome
3.3 Technological Approach for NIPT
3.4 Patent Landscape
3.4.1 Major Patents issued to Sequenom, Inc.
3.4.2 Major Patents issued to Ariosa Diagnostics, Inc.
3.4.3 Major Patents issued to Natera, Inc.
3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.)
3.4.5 Major Patents issued to Cellscape Corporation
3.5 Market Drivers
3.5.1 High incidence rate of babies born with Down syndrome
3.5.2 Globally rising average maternal age
3.5.3 Increasing demand for early and non-invasive fetal testing procedures
3.6 Market Restraints
3.6.1 Regulatory guidelines and ethical hurdles
3.6.2 Limitations of NIPT
3.6.3 Availability of other screening and testing methods
3.7 Market Opportunities
3.7.1 Capitalizing on the potential presented by the emerging markets of Asia
3.8 Porter’s Five Force Analysis: Global Non-Invasive Prenatal testing Market
3.8.1 Bargaining power of suppliers
3.8.2 Bargaining power of buyers
3.8.3 Threat of substitutes
3.8.4 Threat of new entrants
3.8.5 Competitive rivalry
3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
3.9.1 Market Attractive Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
3.10 Competitive Landscape
3.10.1 Market Share Analysis, by Key Players, 2013 (%)
3.10.2 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013(%)
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
You must log in to post a comment.